Literature DB >> 6347209

Microscopic studies of Candida albicans and Torulopsis glabrata after in vitro treatment with bifonazole. Light and scanning electron microscopy.

D Barug, R A Samson, A Kerkenaar.   

Abstract

1-[(4-Biphenylyl)-phenylmethyl]-1H-imidazole (bifonazole, Bay h 4502, Mycospor) preferentially inhibited yeast-hypha conversion in the dimorphic fungus Candida albicans. As observed by phase-contrast and scanning electron microscopy the morphology of C. albicans yeast cells and Torulopsis glabrata cells markedly altered after treatment with bifonazole. Whereas control cells were mostly occurring singly, the bifonazole-treated cells did not separate, resulting in the formation of chains and clusters of interconnected cells. Furthermore, in contrast with control cells bifonazole-treated cells of C. albicans and T. glabrata were almost spherical in shape. Evidence is presented by means of fluorescence microscopy that bifonazole-treated yeast cells of C. albicans frequently lacked septa and often contained irregular deposition of chitin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347209

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  New fluorescence assay for the quantitation of fungi.

Authors:  T Coleman; J V Madassery; G S Kobayashi; M H Nahm; J R Little
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

Review 2.  Bifonazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses.

Authors:  T E Lackner; S P Clissold
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

3.  Effects of cyclopropenoid fatty acids on fungal growth and lipid composition.

Authors:  K M Schmid; G W Patterson
Journal:  Lipids       Date:  1988-03       Impact factor: 1.880

4.  Azole-induced cell wall carbohydrate patches kill Aspergillus fumigatus.

Authors:  Bernadette Geißel; Veronika Loiko; Isabel Klugherz; Zhaojun Zhu; Nikola Wagener; Oliver Kurzai; Cees A M J J van den Hondel; Johannes Wagener
Journal:  Nat Commun       Date:  2018-08-06       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.